Overview

Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of ONTAK in previously treated patients with chronic lymphocytic leukemia (CLL)
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Denileukin diftitox